IXO (Irinotecan, Xeloda, Oxaliplatin) in Rectal Cancer
Clinical trial NCT01237665 · UNKNOWN
Trial details
- NCT number
- NCT01237665
- Sponsor
- Ottawa Hospital Research Institute
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2010-09-01
- Primary completion
- 2012-12-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.